1 January 2026 in Journal of Ophthalmology
Purpose: To validate a novel VISULYZE‐based nomogram for high myopia in small incision lenticule extraction (SMILE) surgery. Methods: This prospective, nonrandomized controlled trial included 118 eyes of 71 high‐myopia patients treated with SMILE using a VisuMax 500‐kHz femtosecond laser. High myopia was defined as a spherical equivalent refraction ≤ −6.00 D. Treated eyes were divided into two groups, according to different nomograms received: the conventional surgeon‐adjusted nomogram group ( n = 71 eyes) and the VISULYZE‐based nomogram group ( n = 47 eyes). The VISULYZE nomogram was generated by the data from 108 myopic eyes that underwent SMILE surgery at 3 months. The visual outcomes followed up for 3 months for both groups were compared for efficacy, safety, predictability, stability, and higher‐order aberrations (HOAs). Results: Preop‐SE was −6.58 ± 0.50 D in the conventional group and −6.79 ± 0.61 D in the VISULYZE group. At 3 months postoperatively, the SE in the conventional group and the VISULYZE group was −0.16 ± 0.34 D and 0.05 ± 0.40 D ( p < 0.05), respectively. It was found that 72% and 100% had a UDVA of 20/20 in the conventional group and VISULYZE group, respectively, while 89% and 99% had an SE within ±0.5 D and ±1.0 D in the conventional group and 89% and 100% in the VISULYZE group. The efficacy indexes were 0.97 ± 0.07 in the conventional group and 1.02 ± 0.06 in the VISULYZE group ( p < 0.05). The safety indexes were 1.15 ± 0.10 in the conventional group and 1.15 ± 0.15 in the VISULYZE group ( p > 0.05), respectively. The VISULYZE‐based nomogram was associated with lower induction of 3rd‐order vertical/horizontal coma, total coma, 4th‐order spherical aberration, and root mean square (RMS) HOAs. Conclusions: The VISULYZE‐based nomogram demonstrated comparable safety to the conventional nomogram while achieving significantly superior efficacy and predictability. Additionally, it provided a supportive condition for reducing RMS HOAs after SMILE compared to the conventional approach. Trial Registration: ClinicalTrials.gov: NCT06982807